Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Disposable Syringe	NCIT_C68968
Plastic Bag for Injectable Solution	NCIT_C68969
Bag	NCIT_C43167	[A sac or pouch.]
Calcifying Cystic Odontogenic Tumor	NCIT_C54319	[A benign, intraosseous or extraosseous cystic neoplasm arising from tooth-forming tissues. It is characterized by the presence of a cyst lined by an ameloblastoma-like epithelium and ghost cells formation. The ghost cells may undergo calcification. It is treated with enucleation. Few recurrences have been reported for intraosseous neoplasms whereas no recurrences have been reported for extraosseous neoplasms.]
Seizure, CTCAE 5.0	NCIT_C146700	[A disorder characterized by a sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.]
Enneking Stage IA	NCIT_C146701	[A stage for malignant musculoskeletal tumors characterized by low grade (G1), intracomparmental site (T1), and no metastasis (M0).]
Enneking Staging System	NCIT_C140258	[A staging system for malignant mesenchymal tumors that takes into account the surgical grade, local extent, and presence or absence of metastasis.]
Enneking Stage IB	NCIT_C146702	[A stage for malignant musculoskeletal tumors characterized by low grade (G1), extracomparmental site (T2), and no metastasis (M0).]
Enneking Stage IIA	NCIT_C146703	[A stage for malignant musculoskeletal tumors characterized by high grade (G2), intracomparmental site (T1), and no metastasis (M0).]
Additive Syringe	NCIT_C68970
Enneking Stage IIB	NCIT_C146704	[A stage for malignant musculoskeletal tumors characterized by high grade (G2), intracomparmental site (T2), and no metastasis (M0).]
Intraperitoneal Solution Dosage Form	NCIT_C68971	[A solution intended for administration into the intraperitoneal cavity.]
Enneking Stage III	NCIT_C146705	[A stage for malignant musculoskeletal tumors characterized by any grade, any site, and regional or distant metastasis (M1).]
Pudding Dosage Form	NCIT_C68972	[A semi-solid, having a relatively thick consistency, intended for oral administration to facilitate ease of swallowing.]
Mediastinal/Thymic NUT Carcinoma	NCIT_C146706	[A highly aggressive, poorly differentiated carcinoma that arises from the mediastinum/thymus. It is characterized by mutations and rearrangement of the NUT gene.]
Thoracic NUT Carcinoma	NCIT_C142781	[A highly aggressive, poorly differentiated carcinoma that arises from the thoracic structures. It is characterized by mutations and rearrangement of the NUT gene. It usually presents at an advanced stage with pleuritic chest pain and pleural effusion, non-productive cough, shortness of breath, and weigh loss.]
Gel Forming Solution Dosage Form	NCIT_C68973	[A solution that becomes a gelatinous liquid after administration.]
Bladder Perforation, CTCAE 5.0	NCIT_C146707	[A disorder characterized by a rupture in the bladder wall.]
MFHAS1 wt Allele	NCIT_C54311	[Human MFHAS1 wild-type allele is located in the vicinity of 8p23.1 and is approximately 107 kb in length. This allele, which encodes MASL1 protein, may play a role in cell cycle regulation and oncogenesis. MASL1 allele is a potential oncogene whose expression is enhanced in some malignant fibrous histiocytomas.]
MFHAS1 Gene	NCIT_C24593	[This gene is involved in signal transduction.]